InMed Pharmaceuticals Reports First Quarter Fiscal 2022 Financial Results and Provides Business Update
Ryan Allway November 10th, 2021 VANCOUVER, British Columbia., Nov. 10, 2021 (GLOBE NEWSWIRE) — InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the development, manufacturing and commercialization of rare cannabinoids, today announced financial results for the first quarter of fiscal year 2022 which ended September 30,... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )